Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Reliance on inpatient BP readings may cause overtreatment
Distance traveled for PCI has little effect on veterans’ outcomes
Integrated embolic protection system approved for carotid stenting
Pre-activating cath labs speeds reperfusion, boosts survival for STEMI patients
Racial, socioeconomic disparities in outcomes ‘systemic,’ not hospital-based
2nd carcinogen detected in common heart drug valsartan
PK Papyrus covered stent gains FDA approval to treat coronary perforations
Angiographic completeness of PCI not tied to outcomes after FFR-guided stenting
Wearable ultrasound patch can monitor BP 4 cm below skin
‘Reassuring’ news: Tainted valsartan didn’t increase short-term cancer risk